Showing results (41-50 of 535) with videos related to
Sort By:
Pageof 54
Cancer Research|January 20, 2004
Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapyYoussef Jounaidi, David J WaxmanMethods in Molecular Biology (Clifton, N.J.)|February 26, 2013
DNase I digestion of isolated nulcei for genome-wide mapping of DNase hypersensitivity sites in chromatinGuoyu Ling, David J WaxmanThe Journal of Pharmacology and Experimental Therapeutics|November 30, 2012
Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantroneEugene Manley, David J WaxmanMolecular Cancer Therapeutics|May 3, 2013
Impact of tumor vascularity on responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor modelKexiong Zhang, David J WaxmanMolecular Pharmacology|April 19, 2002
Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stabilityDongxu Liu, David J WaxmanCancer Gene Therapy|August 11, 2001
Modulation of cyclophosphamide-based cytochrome P450 gene therapy using liver P450 inhibitorsZ Huang, D J WaxmanThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistanceG Chen, D J WaxmanReproductive Toxicology (Elmsford, N.Y.)|June 2, 2015
Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studiesAlexander Suvorov, David J WaxmanPageof 54